EA
JNJ icon

Enclave Advisors’s Johnson & Johnson JNJ Stock Holding History

Enclave Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$842K Sell
3,315
-66
-2% -$15.4K 0.11% 75
2026
Q1 		$826K Hold
3,381
– – 0.11% 76
2025
Q4 		$700K Sell
3,381
-11
-0.3% -$2.17K 0.1% 81
2025
Q3 		$629K Sell
3,392
-10
-0.3% -$1.71K 0.1% 71
2025
Q2 		$520K Sell
3,402
-12
-0.4% -$1.84K 0.08% 76
2025
Q1 		$566K Sell
3,414
-12
-0.4% -$1.88K 0.1% 68
2024
Q4 		$495K Sell
3,426
-408
-11% -$63.2K 0.08% 78
2024
Q3 		$621K Buy
+3,834
New +$611K 0.11% 72

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Enclave Advisors's JNJ Position: Q2 2026 in Review

Enclave Advisors reduced its Johnson & Johnson (JNJ) stake by 2% in Q2 2026, selling an estimated $15.4K and leaving 3,315 shares worth $842K. The position accounts for 0.11% of the portfolio, ranked #75.

Enclave Advisors first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Enclave Advisors held 3,315 shares of Johnson & Johnson worth $842K as of Q2 2026.
  • Enclave Advisors sold 66 Johnson & Johnson shares in Q2 2026, an estimated $15.4K.
  • Johnson & Johnson made up 0.11% of Enclave Advisors's portfolio in Q2 2026, its #75 holding.
  • Enclave Advisors first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Enclave Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.